NEU neuren pharmaceuticals limited

A pertinent point hottod and partially for these reasons I do...

  1. 2,749 Posts.
    lightbulb Created with Sketch. 1051
    A pertinent point hottod and partially for these reasons I do not think we will 'accept' a takeover now.

    I would not at all be surprised to discover the board has received lowball/opportunistic informal offers that have been dismissed out of hand.

    I also expect the shareprice to rise over coming months on the back of new indications, confirmation of endpoints, and confirmation of Ph3 timeline and its approach. Finally I suspect that if we make it to Ph3 results, and they are as good as I expect, than we will see something similar to what happened last time with trofinetide/Retts, where we went up 700% or so post results and that any takeover premium will be on that figure and not on $14.39.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.59
Change
1.045(8.33%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.96 $13.65 $12.91 $3.031M 227.5K

Buyers (Bids)

No. Vol. Price($)
6 301 $13.57
 

Sellers (Offers)

Price($) Vol. No.
$13.60 1574 5
View Market Depth
Last trade - 10.18am 26/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.